SCHEMBL25438497

SCHEMBL25438497

CCN(CC)C(=O)C(=O)c1c[nH]c2ccc(C)c(OC)c12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MITF O75030 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ NR4A2 P43354 2/20 0.34
▸ MAOA P21397 1/20 0.34
▸ HTR1D P28221 2/20 0.33
▸ HTR1B P28222 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25436274 0.89 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25748171 0.86 ALDH1A1 (0.36) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25748082 0.86 NR4A2 (0.36) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25748258 0.83 PTPN1 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2HTR1D
SCHEMBL25423189 0.82 NR4A2 (0.34) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25423229 0.81 NR4A2 (0.33) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25425896 0.80 NR4A2 (0.40) MEN1KMT2AMITFLMNAMAPT
SCHEMBL25748562 0.79 HTR1A (0.48) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL17417754 0.78 HSD17B10 (0.43) ALDH1A1MEN1KMT2ACYP1A2MITF
SCHEMBL22864639 0.77 NR4A2 (0.55) NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB ALDH1A1 981/4885MEN1 1401/4885KMT2A 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback